Interest in Ru anticancer drugs has been growing rapidly since NAMI-A ((ImH+)[RuIIICl4
(Im)(S-dmso)], where Im= imidazole and S-dmso= S-bound dimethylsulfoxide) or KP1019 …

Approximately one third of the human proteome contains metal cations, either in the form of
cofactors with catalytic functions or as structural support elements. 1, 2 To guarantee a …

Studies of metal uptake, metabolism and excretion by single bacterial, yeast, plant and
animal cells is a widespread area of research, yet little is known about the reactivity and …

The biochemistry of chromium (III) has been a poorly understood field of endeavor. Despite
four decades of investigation, only recently has a somewhat clear picture of the role of Cr …

The status of Cr (III) as an essential micronutrient for humans is currently under question. No
functional Cr (III)-containing biomolecules have been definitively described as yet, and …

This review focusses on the significance of fluorescent, phosphorescent labelling and
tracking of extracellular vesicles (EVs) for unravelling their biology, pathophysiology, and …

As synchrotron light sources and optics deliver greater photon flux on samples, X-ray-
induced photo-chemistry is increasingly encountered in X-ray absorption spectroscopy …

The current status and likely future directions of complexes of V (V/IV), Cr (III), Mo (VI), W (VI),
Zn (II), Cu (II), and Mn (III) as potential oral drugs against type 2 diabetes are reviewed. We …

Interest in ruthenium-based anti-metastatic drugs with low cytotoxicity is rapidly growing,[1–
3] for example, NAMI-A (1, Figure 1)[2] has completed phase I clinical trials.[4] Although its …

Reactions with blood components are crucial for controlling the antidiabetic, anticancer, and
other biological activities of V (V) and V (IV) complexes. Despite extensive studies of V (V) …